Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Example: marketing
Public Assessment Report Decentralised Procedure …
Public Assessment Report Decentralised Procedure BINOSTO 70 mg effervescent tablets (alendronate sodium) UK/H/3515/001/DC UK licence no: PL 42786/0001 EFFRX PHARMA GMBH PAR Binosto 70 mg effervescent tablets UK/H/3515/001/DC 2 LAY SUMMARY Binosto 70 mg effervescent tablets (alendronate sodium trihydrate ( alendronic acid ), effervescent tablets , 70 mg) This is a summary of the Public Assessment Report (PAR) for Binosto 70 mg effervescent tablets . It explains how Binosto 70 mg effervescent tablets was assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use Binosto 70 mg effervescent tablets .
PAR Binosto 70 mg effervescent tablets UK/H/3515/001/DC 3 How do Binosto 70 mg effervescent tablets, work? The active ingredient (alendronic acid) in this medicine belongs to a group of non-hormonal
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: